BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu J, Santesso N, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ. Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med 2012;156:512-24. [PMID: 22371849 DOI: 10.7326/0003-4819-156-7-201204030-00411] [Cited by in Crossref: 164] [Cited by in F6Publishing: 151] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study. PLoS One 2012;7:e43491. [PMID: 22984431 DOI: 10.1371/journal.pone.0043491] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
2 Motisi MA, Tamborino A, Parigi S, Galli L, de Martino M, Chiappini E. The use of antiviral drugs in children. J Chemother 2021;:1-14. [PMID: 34633268 DOI: 10.1080/1120009X.2021.1979746] [Reference Citation Analysis]
3 Abdel-ghaffar WH, Abdelghffar EA. Pathophysiological effects of Tamiflu on liver and kidneys of male rats. Beni-Suef Univ J Basic Appl Sci 2022;11. [DOI: 10.1186/s43088-021-00189-6] [Reference Citation Analysis]
4 Hill AT, Gold PM, El Solh AA, Metlay JP, Ireland B, Irwin RS; CHEST Expert Cough Panel. Adult Outpatients With Acute Cough Due to Suspected Pneumonia or Influenza: CHEST Guideline and Expert Panel Report. Chest 2019;155:155-67. [PMID: 30296418 DOI: 10.1016/j.chest.2018.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
5 Beigi RH. Prevention and management of influenza in pregnancy. Obstet Gynecol Clin North Am 2014;41:535-46. [PMID: 25454989 DOI: 10.1016/j.ogc.2014.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
6 Pereira AKDS, Santos IA, da Silva WW, Nogueira FAR, Bergamini FRG, Jardim ACG, Corbi PP. Memantine hydrochloride: a drug to be repurposed against Chikungunya virus? Pharmacol Rep 2021;73:954-61. [PMID: 33523405 DOI: 10.1007/s43440-021-00216-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dou L, Reynolds D, Wallace L, O'Horo J, Kashyap R, Gajic O, Yadav H. Decreased Hospital Length of Stay With Early Administration of Oseltamivir in Patients Hospitalized With Influenza. Mayo Clin Proc Innov Qual Outcomes 2020;4:176-82. [PMID: 32280928 DOI: 10.1016/j.mayocpiqo.2019.12.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Chan MC, Lee N, Ngai KL, Leung TF, Chan PK. Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children. J Clin Microbiol 2014;52:497-501. [PMID: 24478479 DOI: 10.1128/JCM.02316-13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
9 Haffizulla J, Hartman A, Hoppers M, Resnick H, Samudrala S, Ginocchio C, Bardin M, Rossignol JF; US Nitazoxanide Influenza Clinical Study Group. Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial. Lancet Infect Dis 2014;14:609-18. [PMID: 24852376 DOI: 10.1016/S1473-3099(14)70717-0] [Cited by in Crossref: 143] [Cited by in F6Publishing: 84] [Article Influence: 17.9] [Reference Citation Analysis]
10 Zhang J, Hu Y, Musharrafieh R, Yin H, Wang J. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development. Curr Med Chem 2019;26:2243-63. [PMID: 29984646 DOI: 10.2174/0929867325666180706112940] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
11 Siegel SJ, Roche AM, Weiser JN. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 2014;16:55-67. [PMID: 25011108 DOI: 10.1016/j.chom.2014.06.005] [Cited by in Crossref: 152] [Cited by in F6Publishing: 131] [Article Influence: 21.7] [Reference Citation Analysis]
12 El Ramahi R, Freifeld A. Epidemiology, Diagnosis, Treatment, and Prevention of Influenza Infection in Oncology Patients. J Oncol Pract 2019;15:177-84. [PMID: 30970229 DOI: 10.1200/JOP.18.00567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
13 Beigi RH, Venkataramanan R, Caritis SN. Oseltamivir for influenza in pregnancy. Semin Perinatol 2014;38:503-7. [PMID: 25281358 DOI: 10.1053/j.semperi.2014.08.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
14 Heneghan CJ, Onakpoya I, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Mahtani KR, Nunan D, Howick J, Jefferson T. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess 2016;20:1-242. [PMID: 27246259 DOI: 10.3310/hta20420] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 11.5] [Reference Citation Analysis]
15 Lenoir-Wijnkoop I, Gerlier L, Roy D, Reid G. The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada. PLoS One 2016;11:e0166232. [PMID: 27832195 DOI: 10.1371/journal.pone.0166232] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
16 Weng TC, Chiu HR, Chen SY, Shih FY, King CC, Fang CC. National retrospective cohort study to identify age-specific fatality risks of comorbidities among hospitalised patients with influenza-like illness in Taiwan. BMJ Open 2019;9:e025276. [PMID: 31239301 DOI: 10.1136/bmjopen-2018-025276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Cavallazzi R, Ramirez JA. Influenza and Viral Pneumonia. Clin Chest Med 2018;39:703-21. [PMID: 30390743 DOI: 10.1016/j.ccm.2018.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
18 Ibrahim H, Kamour AM, Harhara T, Gaba WH, Nair SC. Covid-19 pandemic research opportunity: Is the Middle East & North Africa (MENA) missing out? Contemp Clin Trials 2020;96:106106. [PMID: 32781230 DOI: 10.1016/j.cct.2020.106106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
19 Van Wesenbeeck L, D'Haese D, Tolboom J, Meeuws H, Dwyer DE, Holmes M, Ison MG, Katz K, McGeer A, Sadoff J, Weverling GJ, Stuyver L. A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients. Open Forum Infect Dis 2015;2:ofv166. [PMID: 26677457 DOI: 10.1093/ofid/ofv166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
20 Vardakas KZ, Theocharis G, Tansarli GS, Rafailidis P, Falagas ME. Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study. Arch Virol 2016;161:2511-8. [PMID: 27368992 DOI: 10.1007/s00705-016-2941-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
21 Kamal MA, Smith PF, Chaiyakunapruk N, Wu DBC, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Kirkpatrick CM, Rayner CR. Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics. Br J Clin Pharmacol 2017;83:1580-94. [PMID: 28176362 DOI: 10.1111/bcp.13229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 5.4] [Reference Citation Analysis]
22 Li Y, Xu J, Shi W, Chen C, Shao Y, Zhu L, Lu W, Han X. Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice. Stem Cell Res Ther 2016;7:159. [PMID: 27793190 DOI: 10.1186/s13287-016-0395-z] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 10.2] [Reference Citation Analysis]
23 Takeda S, Hisano M, Komano J, Yamamoto H, Sago H, Yamaguchi K. Influenza vaccination during pregnancy and its usefulness to mothers and their young infants. J Infect Chemother 2015;21:238-46. [PMID: 25708925 DOI: 10.1016/j.jiac.2015.01.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
24 Tan KX, Jacob SA, Chan KG, Lee LH. An overview of the characteristics of the novel avian influenza A H7N9 virus in humans. Front Microbiol 2015;6:140. [PMID: 25798131 DOI: 10.3389/fmicb.2015.00140] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
25 Storms AD, Kusriastuti R, Misriyah S, Praptiningsih CY, Amalya M, Lafond KE, Samaan G, Triada R, Iuliano AD, Ester M, Sidjabat R, Chittenden K, Vogel R, Widdowson MA, Mahoney F, Uyeki TM. The East Jakarta Project: surveillance for highly pathogenic avian influenza A(H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011-September 2012. Epidemiol Infect 2015;143:3394-404. [PMID: 25912029 DOI: 10.1017/S0950268815000771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Hu Y, Zhang J, Musharrafieh R, Hau R, Ma C, Wang J. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral. Int J Mol Sci 2017;18:E1929. [PMID: 28885544 DOI: 10.3390/ijms18091929] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
27 Santesso N, Hsu J, Mustafa R, Brozek J, Chen YL, Hopkins JP, Cheung A, Hovhannisyan G, Ivanova L, Flottorp SA, Saeterdal I, Wong AD, Tian J, Uyeki TM, Akl EA, Alonso-Coello P, Smaill F, Schünemann HJ. Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies. Influenza Other Respir Viruses 2013;7 Suppl 2:76-81. [PMID: 24034489 DOI: 10.1111/irv.12085] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
28 Liu G, Xiang Y, Guo C, Pei Y, Wang Y, Kitazato K. Cofilin-1 is involved in regulation of actin reorganization during influenza A virus assembly and budding. Biochemical and Biophysical Research Communications 2014;453:821-5. [DOI: 10.1016/j.bbrc.2014.10.036] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
29 Duerrwald R, Schlegel M, Bauer K, Vissiennon T, Wutzler P, Schmidtke M. Efficacy of influenza vaccination and tamiflu® treatment--comparative studies with Eurasian Swine influenza viruses in pigs. PLoS One 2013;8:e61597. [PMID: 23630601 DOI: 10.1371/journal.pone.0061597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
30 Pavia AT. What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia? Infect Dis Clin North Am 2013;27:157-75. [PMID: 23398872 DOI: 10.1016/j.idc.2012.11.007] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 4.7] [Reference Citation Analysis]
31 Chow EJ, Doyle JD, Uyeki TM. Influenza virus-related critical illness: prevention, diagnosis, treatment. Crit Care 2019;23:214. [PMID: 31189475 DOI: 10.1186/s13054-019-2491-9] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
32 Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019;68:e1-e47. [PMID: 30566567 DOI: 10.1093/cid/ciy866] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 83.0] [Reference Citation Analysis]
33 Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. J Infect Dis 2013;207:553-63. [PMID: 23204175 DOI: 10.1093/infdis/jis726] [Cited by in Crossref: 133] [Cited by in F6Publishing: 113] [Article Influence: 13.3] [Reference Citation Analysis]
34 López-Medrano F, Cordero E, Gavaldá J, Cruzado JM, Marcos MÁ, Pérez-Romero P, Sabé N, Gómez-Bravo MÁ, Delgado JF, Cabral E, Carratalá J; Study Group of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases, Clinical Microbiology (SEIMC), Spanish Network for Research in Infectious Diseases (REIPI). Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enferm Infecc Microbiol Clin 2013;31:526.e1-526.e20. [PMID: 23528341 DOI: 10.1016/j.eimc.2013.01.013] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
35 Ison MG. Editorial Commentary: Failing Our Patients by Suboptimally Treating Influenza Infections. Clinical Infectious Diseases 2014;59:783-6. [DOI: 10.1093/cid/ciu425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
36 Aoki Y, Amaya Dimas LDC, Kitazawa K, Mizushiro N. Reconstitution of Oseltamivir Capsules for Pediatric Use on a Long-Term Cruise: A Treatment Option. Wilderness Environ Med 2021;32:74-7. [PMID: 33431303 DOI: 10.1016/j.wem.2020.09.008] [Reference Citation Analysis]
37 Ison MG. Antiviral Treatments. Clin Chest Med 2017;38:139-53. [PMID: 28159156 DOI: 10.1016/j.ccm.2016.11.008] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
38 Hartman L, Zhu Y, Edwards KM, Griffin MR, Talbot HK. Underdiagnosis of Influenza Virus Infection in Hospitalized Older Adults. J Am Geriatr Soc 2018;66:467-72. [PMID: 29341100 DOI: 10.1111/jgs.15298] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
39 Watson SI, Chen YF, Nguyen-Van-Tam JS, Myles PR, Venkatesan S, Zambon M, Uthman O, Chilton PJ, Lilford RJ. Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage. F1000Res 2016;5:2293. [PMID: 28413608 DOI: 10.12688/f1000research.9414.2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
40 Chen C, Wang P, Zhang L. A two-thresholds policy for a Filippov model in combating influenza. J Math Biol 2020;81:435-61. [PMID: 32588119 DOI: 10.1007/s00285-020-01514-w] [Reference Citation Analysis]
41 Luyt CE, Kaiser L. Virus detection in patients with severe pneumonia: still more questions than answers? Am J Respir Crit Care Med 2012;186:301-2. [PMID: 22896590 DOI: 10.1164/rccm.201206-1119ED] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
42 Kwon YS, Park SH, Kim MA, Kim HJ, Park JS, Lee MY, Lee CW, Dauti S, Choi WI. Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infect Dis 2017;17:785. [PMID: 29262784 DOI: 10.1186/s12879-017-2897-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
43 Kardos P. Phytotherapy in acute bronchitis: what is the evidence? Clin Phytosci 2015;1. [DOI: 10.1186/s40816-015-0003-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
44 Dugas AF, Valsamakis A, Gaydos CA, Forman M, Hardick J, Kidambi P, Amin S, Gupta A, Rothman RE. Evaluation of the Xpert Flu rapid PCR assay in high-risk emergency department patients. J Clin Microbiol 2014;52:4353-5. [PMID: 25253792 DOI: 10.1128/JCM.02343-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
45 Henkle E, Irving SA, Naleway AL, Gaglani MJ, Ball S, Spencer S, Peasah S, Thompson MG. Comparison of laboratory-confirmed influenza and noninfluenza acute respiratory illness in healthcare personnel during the 2010-2011 influenza season. Infect Control Hosp Epidemiol 2014;35:538-46. [PMID: 24709723 DOI: 10.1086/675832] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
46 Zhao D, Fukuyama S, Sakai-Tagawa Y, Takashita E, Shoemaker JE, Kawaoka Y. C646, a Novel p300/CREB-Binding Protein-Specific Inhibitor of Histone Acetyltransferase, Attenuates Influenza A Virus Infection. Antimicrob Agents Chemother 2015;60:1902-6. [PMID: 26711748 DOI: 10.1128/AAC.02055-15] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Beigi RH. Influenza During Pregnancy: A Cause of Serious Infection in Obstetrics. Clinical Obstetrics & Gynecology 2012;55:914-26. [DOI: 10.1097/grf.0b013e31827146bd] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
48 Reuss A, Dehnert M, Buda S, Haas W. Differential use of antivirals for treatment of patients with influenza A(H1N1)pdm09 in Germany. Influenza Other Respir Viruses 2013;7:1427-32. [PMID: 23957666 DOI: 10.1111/irv.12152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 McQuade B, Blair M. Influenza treatment with oseltamivir outside of labeled recommendations. Am J Health Syst Pharm 2015;72:112-6. [PMID: 25550133 DOI: 10.2146/ajhp140390] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
50 Lansbury LE, Brown CS, Nguyen-Van-Tam JS. Influenza in long-term care facilities. Influenza Other Respir Viruses 2017;11:356-66. [PMID: 28691237 DOI: 10.1111/irv.12464] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 11.4] [Reference Citation Analysis]
51 Reacher M, Warne B, Reeve L, Verlander NQ, Jones NK, Ranellou K, Christou S, Wright C, Choudhry S, Zambon M, Sander C, Zhang H, Jalal H. Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017. Euro Surveill 2019;24. [PMID: 31690364 DOI: 10.2807/1560-7917.ES.2019.24.44.1900087] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
52 Boikos C, Caya C, Doll MK, Kraicer-Melamed H, Dolph M, Delisle G, Winters N, Gore G, Quach C. Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15. J Antimicrob Chemother 2017;72:1556-73. [PMID: 28204554 DOI: 10.1093/jac/dkx013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
53 Ison MG, Portsmouth S, Yoshida Y, Shishido T, Mitchener M, Tsuchiya K, Uehara T, Hayden FG. Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis 2020;20:1204-14. [PMID: 32526195 DOI: 10.1016/S1473-3099(20)30004-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 21.5] [Reference Citation Analysis]
54 Wu DBC, Chaiyakunapruk N, Pratoomsoot C, Lee KKC, Chong HY, Nelson RE, Smith PF, Kirkpatrick CM, Kamal MA, Nieforth K, Dall G, Toovey S, Kong DCM, Kamauu A, Rayner CR. Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics. Epidemiol Infect 2018;146:496-507. [PMID: 29446343 DOI: 10.1017/S0950268818000158] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
55 Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Iglesias AL, Hoger PH, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Knight M, Kudo K, Kusznierz G, Kuzman I, Kwan AM, Amine IL, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Mayo-Montero E, McGeer A, Memish Z, Metan G, Mickiene A, Mikić D, Mohn KG, Moradi A, Nymadawa P, Oliva ME, Ozkan M, Parekh D, Paul M, Polack FP, Rath BA, Rodríguez AH, Sarrouf EB, Seale AC, Sertogullarindan B, Siqueira MM, Skręt-Magierło J, Stephan F, Talarek E, Tang JW, To KK, Torres A, Törün SH, Tran D, Uyeki TM, Van Zwol A, Vaudry W, Vidmar T, Yokota RT, Zarogoulidis P, Nguyen-Van-Tam JS; PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014;2:395-404. [PMID: 24815805 DOI: 10.1016/S2213-2600(14)70041-4] [Cited by in Crossref: 379] [Cited by in F6Publishing: 180] [Article Influence: 47.4] [Reference Citation Analysis]
56 Beck CR, Sokal R, Arunachalam N, Puleston R, Cichowska A, Kessel A, Zambon M, Nguyen-Van-Tam JS; UK Antiviral Effectiveness Review Group. Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Influenza Other Respir Viruses 2013;7 Suppl 1:14-24. [PMID: 23279893 DOI: 10.1111/irv.12048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
57 Lindegren ML, Griffin MR, Williams JV, Edwards KM, Zhu Y, Mitchel E, Fry AM, Schaffner W, Talbot HK. Antiviral treatment among older adults hospitalized with influenza, 2006-2012. PLoS One 2015;10:e0121952. [PMID: 25807314 DOI: 10.1371/journal.pone.0121952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
58 Hayden FG. Advances in antivirals for non-influenza respiratory virus infections. Influenza Other Respir Viruses 2013;7 Suppl 3:36-43. [PMID: 24215380 DOI: 10.1111/irv.12173] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
59 Wathen MW, Barro M, Bright RA. Antivirals in seasonal and pandemic influenza--future perspectives. Influenza Other Respir Viruses 2013;7 Suppl 1:76-80. [PMID: 23279900 DOI: 10.1111/irv.12049] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
60 Domínguez A, Romero-Tamarit A, Soldevila N, Godoy P, Jané M, Martínez A, Torner N, Caylà JA, Rius C; Surveillance of Hospitalized Cases of Severe Influenza in Catalonia Working Group. Effectiveness of antiviral treatment in preventing death in severe hospitalised influenza cases over six seasons. Epidemiol Infect 2018;146:799-808. [PMID: 29606178 DOI: 10.1017/S0950268818000663] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
61 Malosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS. Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials. Clin Infect Dis 2018;66:1492-500. [PMID: 29186364 DOI: 10.1093/cid/cix1040] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 18.0] [Reference Citation Analysis]
62 Miller PE, Rambachan A, Hubbard RJ, Li J, Meyer AE, Stephens P, Mounts AW, Rolfes MA, Penn CR. Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: summary of an ecological study. Influenza Other Respir Viruses 2013;7 Suppl 2:82-6. [PMID: 24034490 DOI: 10.1111/irv.12092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
63 Dunning J, Baillie JK, Cao B, Hayden FG; International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). Antiviral combinations for severe influenza. Lancet Infect Dis 2014;14:1259-70. [PMID: 25213733 DOI: 10.1016/S1473-3099(14)70821-7] [Cited by in Crossref: 100] [Cited by in F6Publishing: 59] [Article Influence: 12.5] [Reference Citation Analysis]
64 Ratre YK, Vishvakarma NK, Bhaskar LVKS, Verma HK. Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Curr Microbiol. 2020;77:3809-3820. [PMID: 32959089 DOI: 10.1007/s00284-020-02213-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
65 Hirotsu N, Saisho Y, Hasegawa T, Shishido T. Clinical and virologic effects of four neuraminidase inhibitors in influenza A virus-infected children (aged 4–12 years): an open-label, randomized study in Japan. Expert Review of Anti-infective Therapy 2018;16:173-82. [DOI: 10.1080/14787210.2018.1421945] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
66 Nguyen-Van-Tam JS, Openshaw PJ, Nicholson KG. Antivirals for influenza: where now for clinical practice and pandemic preparedness? Lancet 2014;384:386-7. [PMID: 24837882 DOI: 10.1016/S0140-6736(14)60726-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
67 Eşki A, Öztürk GK, Gülen F, Çiçek C, Demir E. Risk Factors for Influenza Virus Related Severe Lower Respiratory Tract Infection in Children. Pediatr Infect Dis J 2019;38:1090-5. [PMID: 31469782 DOI: 10.1097/INF.0000000000002447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
68 Wang Z, Fang J, Luo J, Hou D, Tan Y, Gu Z, Ge Y, Mao L, Liu L, Liu H, Wei Z, Xu H. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo. Viruses 2021;13:278. [PMID: 33670217 DOI: 10.3390/v13020278] [Reference Citation Analysis]
69 Jang Y, Shin JS, Yoon YS, Go YY, Lee HW, Kwon OS, Park S, Park MS, Kim M. Salinomycin Inhibits Influenza Virus Infection by Disrupting Endosomal Acidification and Viral Matrix Protein 2 Function. J Virol 2018;92:e01441-18. [PMID: 30282713 DOI: 10.1128/JVI.01441-18] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
70 Ison MG, Hayden FG. Antiviral Agents Against Respiratory Viruses. Infectious Diseases. Elsevier; 2017. pp. 1318-1326.e2. [DOI: 10.1016/b978-0-7020-6285-8.00154-4] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
71 Brendish NJ, Malachira AK, Lillie PJ, Clark TW. Neuraminidase inhibitor use in adults presenting to hospital with suspected influenza: A questionnaire-based survey of practice among hospital physicians. Clinical Infection in Practice 2021;11:100075. [DOI: 10.1016/j.clinpr.2021.100075] [Reference Citation Analysis]
72 Boni MF, Nguyen TD, de Jong MD, van Doorn HR. Virulence attenuation during an influenza A/H5N1 pandemic. Philos Trans R Soc Lond B Biol Sci 2013;368:20120207. [PMID: 23382429 DOI: 10.1098/rstb.2012.0207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
73 Prada-Ramallal G, Roque F, Herdeiro MT, Takkouche B, Figueiras A. Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals. BMC Med Res Methodol 2018;18:97. [PMID: 30261846 DOI: 10.1186/s12874-018-0561-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Jeyanathan T, Overgaard C, McGeer A. Cardiac complications of influenza infection in 3 adults. CMAJ 2013;185:581-4. [PMID: 23549966 DOI: 10.1503/cmaj.110807] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Pila-Castellanos I, Molino D, McKellar J, Lines L, Da Graca J, Tauziet M, Chanteloup L, Mikaelian I, Meyniel-Schicklin L, Codogno P, Vonderscher J, Delevoye C, Moncorgé O, Meldrum E, Goujon C, Morel E, de Chassey B. Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy. PLoS Pathog 2021;17:e1009340. [PMID: 33596274 DOI: 10.1371/journal.ppat.1009340] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
76 Venkatesan S, Myles PR, Leonardi-Bee J, Muthuri SG, Al Masri M, Andrews N, Bantar C, Dubnov-Raz G, Gérardin P, Koay ESC, Loh TP, Memish Z, Miller E, Oliva ME, Rath BA, Schweiger B, Tang JW, Tran D, Vidmar T, Waight PA, Nguyen-Van-Tam JS. Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis. Clin Infect Dis 2017;64:1328-34. [PMID: 28199524 DOI: 10.1093/cid/cix127] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
77 Aoki FY. Antiviral Drugs for Influenza and Other Respiratory Virus Infections. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2015. pp. 531-545.e5. [DOI: 10.1016/b978-1-4557-4801-3.00044-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Aoki FY, Hayden FG. The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic. J Infect Dis 2013;207:547-9. [PMID: 23204176 DOI: 10.1093/infdis/jis727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
79 Sutton SS, Magagnoli J, Cummings T, Hardin J. Association Between the Use of Antibiotics, Antivirals, and Hospitalizations Among Patients With Laboratory-confirmed Influenza. Clin Infect Dis 2021;72:566-73. [PMID: 31974543 DOI: 10.1093/cid/ciaa074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
80 Pandey P, Karupiah G. Targeting tumour necrosis factor to ameliorate viral pneumonia. FEBS J 2021. [PMID: 33624419 DOI: 10.1111/febs.15782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Chen JL, Kennedy SD, Turner DH. Structural features of a 3' splice site in influenza a. Biochemistry 2015;54:3269-85. [PMID: 25909229 DOI: 10.1021/acs.biochem.5b00012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
82 Huo X, Kamigaki T, Mimura S, Takahashi Y, Oshitani H. Analysis of medical consultation interval between the symptom onset and consultation observed in multiple medical facilities in Odate city, Japan, 2011/2012 and 2012/2013 seasons. J Infect Chemother 2014;20:370-4. [PMID: 24725622 DOI: 10.1016/j.jiac.2014.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
83 Chow EJ, Rolfes MA, O'Halloran A, Alden NB, Anderson EJ, Bennett NM, Billing L, Dufort E, Kirley PD, George A, Irizarry L, Kim S, Lynfield R, Ryan P, Schaffner W, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Respiratory and Nonrespiratory Diagnoses Associated With Influenza in Hospitalized Adults. JAMA Netw Open 2020;3:e201323. [PMID: 32196103 DOI: 10.1001/jamanetworkopen.2020.1323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
84 Duwe S. Influenza viruses - antiviral therapy and resistance. GMS Infect Dis 2017;5:Doc04. [PMID: 30671326 DOI: 10.3205/id000030] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
85 Zimmerman RK, Balasubramani GK, Nowalk MP, Eng H, Urbanski L, Jackson ML, Jackson LA, McLean HQ, Belongia EA, Monto AS, Malosh RE, Gaglani M, Clipper L, Flannery B, Wisniewski SR. Classification and Regression Tree (CART) analysis to predict influenza in primary care patients. BMC Infect Dis 2016;16:503. [PMID: 27659721 DOI: 10.1186/s12879-016-1839-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
86 Shindo N, Briand S. Influenza at the beginning of the 21st century. Bull World Health Organ 2012;90:247-247A. [PMID: 22511816 DOI: 10.2471/BLT.12.104653] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
87 Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019;68:895-902. [PMID: 30834445 DOI: 10.1093/cid/ciy874] [Cited by in Crossref: 119] [Cited by in F6Publishing: 97] [Article Influence: 59.5] [Reference Citation Analysis]
88 López-Medrano F, Fariñas MC, Payeras A, Pachón J. Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic. Enferm Infecc Microbiol Clin 2012;30 Suppl 4:49-53. [PMID: 23116793 DOI: 10.1016/S0213-005X(12)70105-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
89 Haglund S, Quttineh M, Nilsson Bowers A, Matussek A, Henningsson AJ. Xpert Flu as a rapid diagnostic test for respiratory tract viral infection: evaluation and implementation as a 24/7 service. Infectious Diseases 2018;50:140-4. [DOI: 10.1080/23744235.2017.1380841] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
90 Soldevila N, Toledo D, Ortiz de Lejarazu R, Tamames S, Castilla J, Astray J, Fernández MA, Martín V, Egurrola M, Morales Suárez-Varela M, Domínguez À; Working Group of Project PI12/02079. Effect of antiviral treatment in older patients hospitalized with confirmed influenza. Antiviral Res 2020;178:104785. [PMID: 32234540 DOI: 10.1016/j.antiviral.2020.104785] [Reference Citation Analysis]
91 Uyeki TM. Oseltamivir Treatment of Influenza in Children. Clin Infect Dis 2018;66:1501-3. [PMID: 29315362 DOI: 10.1093/cid/cix1150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
92 Wang J, Li F, Ma C. Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses. Biopolymers 2015;104:291-309. [PMID: 25663018 DOI: 10.1002/bip.22623] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 7.0] [Reference Citation Analysis]
93 Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database Syst Rev 2014;:CD002745. [PMID: 25415374 DOI: 10.1002/14651858.CD002745.pub4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
94 Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM. Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun 2013;4:2854. [PMID: 24326875 DOI: 10.1038/ncomms3854] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 15.1] [Reference Citation Analysis]
95 South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: double blind randomised controlled trial. BMJ 2013;346:f3039. [PMID: 23723457 DOI: 10.1136/bmj.f3039] [Cited by in Crossref: 79] [Cited by in F6Publishing: 69] [Article Influence: 8.8] [Reference Citation Analysis]
96 Barauskas O, Xing W, Aguayo E, Willkom M, Sapre A, Clarke M, Birkus G, Schultz BE, Sakowicz R, Kwon H, Feng JY. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs. PLoS One 2017;12:e0185998. [PMID: 29020100 DOI: 10.1371/journal.pone.0185998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
97 Hunter J, Arentz S, Goldenberg J, Yang G, Beardsley J, Myers SP, Mertz D, Leeder S. Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials. BMJ Open 2021;11:e047474. [PMID: 34728441 DOI: 10.1136/bmjopen-2020-047474] [Reference Citation Analysis]
98 Abraham MK, Perkins J, Vilke GM, Coyne CJ. Influenza in the Emergency Department: Vaccination, Diagnosis, and Treatment: Clinical Practice Paper Approved by American Academy of Emergency Medicine Clinical Guidelines Committee. J Emerg Med 2016;50:536-42. [PMID: 26763858 DOI: 10.1016/j.jemermed.2015.10.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
99 Kuehl PJ, Chand R, McDonald JD, Hava DL, DeHaan WH. Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets. AAPS PharmSciTech 2019;20:242. [PMID: 31264190 DOI: 10.1208/s12249-019-1382-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
100 Kositpantawong N, Surasombatpattana S, Siripaitoon P, Kanchanasuwan S, Hortiwakul T, Charernmak B, Nwabor OF, Chusri S. Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia. PLoS One 2021;16:e0261411. [PMID: 34910777 DOI: 10.1371/journal.pone.0261411] [Reference Citation Analysis]
101 Park JH, Cho H, Moon S, Song JH, Kim JY, Ahn YS. Effect of rapid influenza diagnostic tests on patient management in an emergency department. Clin Exp Emerg Med 2019;6:43-8. [PMID: 30781942 DOI: 10.15441/ceem.17.281] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 De Clercq E. Dancing with chemical formulae of antivirals: A panoramic view (Part 2). Biochemical Pharmacology 2013;86:1397-410. [DOI: 10.1016/j.bcp.2013.09.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
103 Hagan RS, Torres-Castillo J, Doerschuk CM. Myeloid TBK1 Signaling Contributes to the Immune Response to Influenza. Am J Respir Cell Mol Biol 2019;60:335-45. [PMID: 30290124 DOI: 10.1165/rcmb.2018-0122OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
104 Liu JW, Lin SH, Wang LC, Chiu HY, Lee JA. Comparison of Antiviral Agents for Seasonal Influenza Outcomes in Healthy Adults and Children: A Systematic Review and Network Meta-analysis. JAMA Netw Open 2021;4:e2119151. [PMID: 34387680 DOI: 10.1001/jamanetworkopen.2021.19151] [Reference Citation Analysis]
105 Pai M, Iorio A, Meerpohl J, Taruscio D, Laricchiuta P, Mincarone P, Morciano C, Leo CG, Sabina S, Akl E, Treweek S, Djulbegovic B, Schunemann H; Consortium for the RARE-Bestpractices. Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices. Rare Diseases 2015;3:e1058463. [DOI: 10.1080/21675511.2015.1058463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
106 Assaf-Casals A, Saleh Z, Khafaja S, Fayad D, Ezzeddine H, Saleh M, Chamseddine S, Sayegh R, Sharara SL, Chmaisse A, Kanj SS, Kanafani Z, Hanna-Wakim R, Araj GF, Mahfouz R, Saito R, Suzuki H, Zaraket H, Dbaibo GS. The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience. BMC Infect Dis 2020;20:339. [PMID: 32397965 DOI: 10.1186/s12879-020-05013-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Selim HS, Hashish MH. Performance of a rapid test versus real-time PCR for diagnosis of H1N1 swine flu. J Egypt Public Health Assoc 2014;89:96-9. [PMID: 25162742 DOI: 10.1097/01.EPX.0000452224.96616.42] [Reference Citation Analysis]
108 Mikasa K, Aoki N, Aoki Y, Abe S, Iwata S, Ouchi K, Kasahara K, Kadota J, Kishida N, Kobayashi O, Sakata H, Seki M, Tsukada H, Tokue Y, Nakamura-Uchiyama F, Higa F, Maeda K, Yanagihara K, Yoshida K. JAID/JSC Guidelines for the Treatment of Respiratory Infectious Diseases: The Japanese Association for Infectious Diseases/Japanese Society of Chemotherapy - The JAID/JSC Guide to Clinical Management of Infectious Disease/Guideline-preparing Committee Respiratory Infectious Disease WG. J Infect Chemother 2016;22:S1-S65. [PMID: 27317161 DOI: 10.1016/j.jiac.2015.12.019] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
109 Bernardo CO, Gonzalez-Chica D, Stocks N. Influenza-like illness and antimicrobial prescribing in Australian general practice from 2015 to 2017: a national longitudinal study using the MedicineInsight dataset. BMJ Open 2019;9:e026396. [PMID: 31048440 DOI: 10.1136/bmjopen-2018-026396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
110 Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients 2015;7:4240-70. [PMID: 26035247 DOI: 10.3390/nu7064240] [Cited by in Crossref: 170] [Cited by in F6Publishing: 155] [Article Influence: 24.3] [Reference Citation Analysis]
111 Dinh H, Zhang X, Sweeney J, Yang Y, He Y, Dhawane A, Iyer SS. Glycan based detection and drug susceptibility of influenza virus. Anal Chem 2014;86:8238-44. [PMID: 25007351 DOI: 10.1021/ac501624v] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
112 Chertow DS, Memoli MJ. Bacterial coinfection in influenza: a grand rounds review. JAMA 2013;309:275-82. [PMID: 23321766 DOI: 10.1001/jama.2012.194139] [Cited by in Crossref: 218] [Cited by in F6Publishing: 196] [Article Influence: 24.2] [Reference Citation Analysis]
113 Farrukee R, Hurt AC. Antiviral Drugs for the Treatment and Prevention of Influenza. Curr Treat Options Infect Dis 2017;9:318-32. [DOI: 10.1007/s40506-017-0129-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
114 Sokolow LZ, Naleway AL, Li D, Shifflett P, Reynolds S, Henninger ML, Ferber JR, Odouli R, Irving SA, Thompson MG. Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010–2012. American Journal of Obstetrics and Gynecology 2015;212:202.e1-202.e11. [DOI: 10.1016/j.ajog.2014.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
115 Nath NK, Yasuda N, Rabeh WM, Sahoo SC, Naumov P. Structural Elucidation of the Neuraminidase Inhibitor Zanamivir (Relenza): Creeping and Diffusion for Polymorph Separation. Crystal Growth & Design 2014;14:770-4. [DOI: 10.1021/cg4016383] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
116 Huang HS, Tsai CL, Chang J, Hsu TC, Lin S, Lee CC. Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis. Clin Microbiol Infect 2018;24:1055-63. [PMID: 29208560 DOI: 10.1016/j.cmi.2017.11.018] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 10.2] [Reference Citation Analysis]
117 Chen F, Yang L, Zhai L, Huang Y, Chen F, Duan W, Yang J. Methyl brevifolincarboxylate, a novel influenza virus PB2 inhibitor from Canarium Album (Lour.) Raeusch. Chem Biol Drug Des 2020;96:1280-91. [PMID: 32519462 DOI: 10.1111/cbdd.13740] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
118 Peacock G, Moore C, Uyeki T. Children with special health care needs and preparedness: experiences from seasonal influenza and the 2009 H1N1 influenza pandemic. Disaster Med Public Health Prep 2012;6:91-3. [PMID: 22700014 DOI: 10.1001/dmp.2012.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
119 Fang YH, Hsu TH, Lin TY, Liu CH, Chou SC, Wu JY, Perng PC. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther 2021;19:1039-46. [PMID: 33641583 DOI: 10.1080/14787210.2021.1878025] [Reference Citation Analysis]
120 Shirley M. Baloxavir Marboxil: A Review in Acute Uncomplicated Influenza. Drugs 2020;80:1109-18. [PMID: 32601915 DOI: 10.1007/s40265-020-01350-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
121 Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jernigan DB. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic. Journal of Clinical Virology 2014;60:27-33. [DOI: 10.1016/j.jcv.2014.01.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
122 Doll MK, Winters N, Boikos C, Kraicer-Melamed H, Gore G, Quach C. Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. J Antimicrob Chemother 2017;72:2990-3007. [PMID: 28961794 DOI: 10.1093/jac/dkx271] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 9.8] [Reference Citation Analysis]
123 Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ 2013;347:f5061. [PMID: 23974637 DOI: 10.1136/bmj.f5061] [Cited by in Crossref: 301] [Cited by in F6Publishing: 272] [Article Influence: 33.4] [Reference Citation Analysis]
124 Fica A, Sotomayor V, Fasce R, Dabanch J, Soto A, Charpentier P, Guerrero G, Olivares F, Triantafilo V, Omeiri NE, Gaínza-Lein M. Severe acute respiratory infections (SARI) from influenza in adult patients in Chile: the experience of a sentinel hospital. Rev Panam Salud Publica 2019;43:e1. [PMID: 31093225 DOI: 10.26633/RPSP.2019.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Nelson RE, Stockmann C, Hersh AL, Pavia AT, Korgenksi K, Daly JA, Couturier MR, Ampofo K, Thorell EA, Doby EH, Robison JA, Blaschke AJ. Economic analysis of rapid and sensitive polymerase chain reaction testing in the emergency department for influenza infections in children. Pediatr Infect Dis J 2015;34:577-82. [PMID: 25973935 DOI: 10.1097/INF.0000000000000703] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 7.7] [Reference Citation Analysis]
126 Deng JC. Viral-bacterial interactions-therapeutic implications. Influenza Other Respir Viruses 2013;7 Suppl 3:24-35. [PMID: 24215379 DOI: 10.1111/irv.12174] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
127 Gupta YK, Meenu M, Mohan P. The Tamiflu fiasco and lessons learnt. Indian J Pharmacol 2015;47:11-6. [PMID: 25821304 DOI: 10.4103/0253-7613.150308] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
128 Chartrand C, Pai M. How accurate are rapid influenza diagnostic tests? Expert Review of Anti-infective Therapy 2014;10:615-7. [DOI: 10.1586/eri.12.49] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
129 De Clercq E, Li G. Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev. 2016;29:695-747. [PMID: 27281742 DOI: 10.1128/cmr.00102-15] [Cited by in Crossref: 592] [Cited by in F6Publishing: 276] [Article Influence: 98.7] [Reference Citation Analysis]
130 Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. The Lancet 2015;385:1729-37. [DOI: 10.1016/s0140-6736(14)62449-1] [Cited by in Crossref: 307] [Cited by in F6Publishing: 145] [Article Influence: 43.9] [Reference Citation Analysis]
131 Ohji G, Doi A, Yamamoto S, Iwata K. Is de-escalation of antimicrobials effective? A systematic review and meta-analysis. Int J Infect Dis 2016;49:71-9. [PMID: 27292606 DOI: 10.1016/j.ijid.2016.06.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
132 Beard KR, Brendish NJ, Clark TW. Treatment of influenza with neuraminidase inhibitors. Curr Opin Infect Dis 2018;31:514-9. [PMID: 30320639 DOI: 10.1097/QCO.0000000000000496] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
133 Rutter P, Mytton O, Ellis B, Donaldson L. Access to the NHS by telephone and Internet during an influenza pandemic: an observational study. BMJ Open 2014;4:e004174. [PMID: 24491382 DOI: 10.1136/bmjopen-2013-004174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
134 Yechezkel M, Ndeffo Mbah ML, Yamin D. Optimizing antiviral treatment for seasonal influenza in the USA: a mathematical modeling analysis. BMC Med 2021;19:54. [PMID: 33641677 DOI: 10.1186/s12916-021-01926-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Margine I, Krammer F. Animal models for influenza viruses: implications for universal vaccine development. Pathogens 2014;3:845-74. [PMID: 25436508 DOI: 10.3390/pathogens3040845] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 8.8] [Reference Citation Analysis]
136 Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour AR, Gheibihayat SM, Raeis-Abdollahi E, Savardashtaki A, Ghanbariasad A, Omidifar N. Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives. Heliyon. 2021;7:e06008. [PMID: 33495739 DOI: 10.1016/j.heliyon.2021.e06008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
137 Rowe E, Ng PY, Chandra T, Chen M, Leo YS. Seasonal Human Influenza: Treatment Options. Curr Treat Options Infect Dis 2014;6:227-44. [PMID: 32288650 DOI: 10.1007/s40506-014-0019-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Lee N, Leo YS, Cao B, Chan PK, Kyaw WM, Uyeki TM, Tam WW, Cheung CS, Yung IM, Li H, Gu L, Liu Y, Liu Z, Qu J, Hui DS. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J 2015;45:1642-52. [PMID: 25573405 DOI: 10.1183/09031936.00169714] [Cited by in Crossref: 63] [Cited by in F6Publishing: 60] [Article Influence: 9.0] [Reference Citation Analysis]
139 Lu H, Chelvanambi S, Poirier C, Saliba J, March KL, Clauss M, Bogatcheva NV. EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury. Mol Ther 2018;26:2060-9. [PMID: 29910176 DOI: 10.1016/j.ymthe.2018.05.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
140 Jennings LC, Smith DW, Chan PK. Report of the first Asia-Pacific Forum on antiviral treatment of influenza, Asia-Pacific Alliance for the Control of Influenza, Bangkok, 14 June 2012. Influenza Other Respir Viruses 2013;7:987-90. [PMID: 23756551 DOI: 10.1111/irv.12130] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
141 Lindegren ML, Schaffner W. Treatment with neuraminidase inhibitors for high-risk patients with influenza: why is adherence to antiviral treatment recommendations so low? J Infect Dis 2014;210:510-3. [PMID: 24731958 DOI: 10.1093/infdis/jiu227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
142 McMillen CM, Beezhold DH, Blachere FM, Othumpangat S, Kashon ML, Noti JD. Inhibition of influenza A virus matrix and nonstructural gene expression using RNA interference. Virology 2016;497:171-84. [PMID: 27474950 DOI: 10.1016/j.virol.2016.07.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
143 Wong H, Eso K, Ip A, Jones J, Kwon Y, Powelson S, de Grood J, Geransar R, Santana M, Joffe AM, Taylor G, Missaghi B, Pearce C, Ghali WA, Conly J. Use of ward closure to control outbreaks among hospitalized patients in acute care settings: a systematic review. Syst Rev 2015;4:152. [PMID: 26546048 DOI: 10.1186/s13643-015-0131-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
144 Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Al Mamun A, Anovadiya AP, Araújo WN, Azziz-Baumgartner E, Báez C, Bantar C, Barhoush MM, Bassetti M, Beovic B, Bingisser R, Bonmarin I, Borja-Aburto VH, Cao B, Carratala J, Cuezzo MR, Denholm JT, Dominguez SR, Duarte PA, Dubnov-Raz G, Echavarria M, Fanella S, Fraser J, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hoffmann M, Hu X, Islam QT, Jiménez MF, Kandeel A, Keijzers G, Khalili H, Khandaker G, Knight M, Kusznierz G, Kuzman I, Kwan AM, Lahlou Amine I, Langenegger E, Lankarani KB, Leo YS, Linko R, Liu P, Madanat F, Manabe T, Mayo-Montero E, McGeer A, Memish ZA, Metan G, Mikić D, Mohn KG, Moradi A, Nymadawa P, Ozbay B, Ozkan M, Parekh D, Paul M, Poeppl W, Polack FP, Rath BA, Rodríguez AH, Siqueira MM, Skręt-Magierło J, Talarek E, Tang JW, Torres A, Törün SH, Tran D, Uyeki TM, van Zwol A, Vaudry W, Velyvyte D, Vidmar T, Zarogoulidis P, Nguyen-Van-Tam JS; PRIDE Consortium Investigators. Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. Influenza Other Respir Viruses 2016;10:192-204. [PMID: 26602067 DOI: 10.1111/irv.12363] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
145 Ludwig A, Lucero-Obusan C, Schirmer P, Winston C, Holodniy M. Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010-2012. BMC Cardiovasc Disord 2015;15:109. [PMID: 26423142 DOI: 10.1186/s12872-015-0095-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
146 Blazoski CM, Baram M, Yang Q, Hirose H. Outcomes of extracorporeal membrane oxygenation in influenza versus COVID-19 during the first wave of COVID-19. J Card Surg 2021. [PMID: 34369601 DOI: 10.1111/jocs.15888] [Reference Citation Analysis]
147 Mitamura K, Kawakami C, Shimizu H, Abe T, Konomi Y, Yasumi Y, Yamazaki M, Ichikawa M, Sugaya N. Evaluation of a new immunochromatographic assay for rapid identification of influenza A, B, and A(H1N1)2009 viruses. J Infect Chemother 2013;19:633-8. [PMID: 23254398 DOI: 10.1007/s10156-012-0533-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
148 O'Hagan JJ, Wong KK, Campbell AP, Patel A, Swerdlow DL, Fry AM, Koonin LM, Meltzer MI. Estimating the United States demand for influenza antivirals and the effect on severe influenza disease during a potential pandemic. Clin Infect Dis 2015;60 Suppl 1:S30-41. [PMID: 25878299 DOI: 10.1093/cid/civ084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
149 Checkmahomed L, Padey B, Pizzorno A, Terrier O, Rosa-Calatrava M, Abed Y, Baz M, Boivin G. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses. Viruses 2020;12:E1139. [PMID: 33049959 DOI: 10.3390/v12101139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
150 Karatas E, Aksoy L, Ozaslan E. Association of Early Favipiravir Use with Reduced COVID-19 Fatality among Hospitalized Patients. Infect Chemother 2021;53:300-7. [PMID: 34216123 DOI: 10.3947/ic.2020.0149] [Reference Citation Analysis]
151 Chow EJ, Rolfes MA, O'Halloran A, Anderson EJ, Bennett NM, Billing L, Chai S, Dufort E, Herlihy R, Kim S, Lynfield R, McMullen C, Monroe ML, Schaffner W, Spencer M, Talbot HK, Thomas A, Yousey-Hindes K, Reed C, Garg S. Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study. Ann Intern Med 2020;173:605-13. [PMID: 32833488 DOI: 10.7326/M20-1509] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 10.5] [Reference Citation Analysis]
152 Nováková L, Pavlík J, Chrenková L, Martinec O, Červený L. Current antiviral drugs and their analysis in biological materials-Part I: Antivirals against respiratory and herpes viruses. J Pharm Biomed Anal 2018;147:400-16. [PMID: 28755849 DOI: 10.1016/j.jpba.2017.06.071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
153 Rodrigo C, Leonardi-bee J, Nguyen-van-tam J, Lim WS, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd010406] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
154 Hama R, Bennett CL. The mechanisms of sudden-onset type adverse reactions to oseltamivir. Acta Neurol Scand 2017;135:148-60. [PMID: 27364959 DOI: 10.1111/ane.12629] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
155 Pereira AKDS, Manzano CM, Nakahata DH, Clavijo JCT, Pereira DH, Lustri WR, Corbi PP. Synthesis, crystal structures, DFT studies, antibacterial assays and interaction assessments with biomolecules of new platinum( ii ) complexes with adamantane derivatives. New J Chem 2020;44:11546-56. [DOI: 10.1039/d0nj02009e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
156 Meng X, Wu Z, Zhang T. THE DYNAMICS AND THERAPEUTIC STRATEGIES OF A SEIS EPIDEMIC MODEL. Int J Biomath 2013;06:1350029. [DOI: 10.1142/s1793524513500290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
157 Venkatesan S, Myles PR, Bolton KJ, Muthuri SG, Al Khuwaitir T, Anovadiya AP, Azziz-Baumgartner E, Bajjou T, Bassetti M, Beovic B, Bertisch B, Bonmarin I, Booy R, Borja-Aburto VH, Burgmann H, Cao B, Carratala J, Chinbayar T, Cilloniz C, Denholm JT, Dominguez SR, Duarte PAD, Dubnov-Raz G, Fanella S, Gao Z, Gérardin P, Giannella M, Gubbels S, Herberg J, Higuera Iglesias AL, Hoeger PH, Hu XY, Islam QT, Jiménez MF, Keijzers G, Khalili H, Kusznierz G, Kuzman I, Langenegger E, Lankarani KB, Leo YS, Libster RP, Linko R, Madanat F, Maltezos E, Mamun A, Manabe T, Metan G, Mickiene A, Mikić D, Mohn KGI, Oliva ME, Ozkan M, Parekh D, Paul M, Rath BA, Refaey S, Rodríguez AH, Sertogullarindan B, Skręt-Magierło J, Somer A, Talarek E, Tang JW, To K, Tran D, Uyeki TM, Vaudry W, Vidmar T, Zarogoulidis P, Nguyen-Van-Tam JS; PRIDE Consortium Investigators. Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. J Infect Dis 2020;221:356-66. [PMID: 31314899 DOI: 10.1093/infdis/jiz152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]